T1	intervention 24 33	metformin
T2	No-of-participants 673 684	Two-hundred
T3	eligibility 685 703	non-diabetic women
T4	control 757 764	placebo
T5	duration 769 776	4Â weeks
T6	outcome-Measure 813 840	ki-67 response to metformin
T7	outcome 1236 1241	ki-67
T8	outcome 1474 1485	drug levels
